Chinese skincare and cosmetic company Park Ha Biological Technology has filed with the SEC to raise up to $7 million in an initial public offering. The company, based in Wuxi, China, plans to offer 1.2 million shares at a price range of $5 to $7, aiming for a market value of $157 million. Park Ha sells skincare products through its own stores and franchises in China. Its product range includes items for skin protection, exfoliation, sebum film repair, microecological balance, and anti-aging, with nearly 200 items across 18 series focusing on problematic skin solutions. Founded in 2016, the company reported $2 million in revenue for the 12 months ending April 30, 2024. Park Ha Biological Technology plans to list on the Nasdaq under the symbol PHH, having filed confidentially on December 29, 2023. The joint bookrunners for the deal are Dawson James and EF Hutton. Investors will be watching to see how the IPO performs and how Park Ha Biological Technology’s products continue to resonate with customers in the competitive Chinese skincare market.
Source
Photo credit www.renaissancecapital.com
Park Ha Biological Technology, a Chinese skincare product company, files for $7 million US IPO, sets terms
